扩展哺乳动物细胞遗传密码的策略
Arianna O Osgood1, Zeyi Huang1, Kaitlyn H Szalay1
1Department of Chemistry, Boston College, 201 Merkert Chemistry Center, 2609 Beacon Street, Chestnut Hill, Massachusetts 02467, United States.
Chemical reviews
|February 12, 2025
概括
哺乳动物细胞中的遗传密码扩展 (GCE) 通过结合非正规氨基酸 (ncAAs) 来实现精确的蛋白质工程. 这种强大的技术为生物研究和开发先进疗法提供了巨大的潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 合成生物学 合成生物学
背景情况:
- 遗传密码扩展 (GCE) 是蛋白质工程的一个关键技术.
- 它允许准确地将非正规氨基酸 (ncAAs) 纳入蛋白质中.
- 这种方法对于研究复杂的细胞过程至关重要.
研究的目的:
- 审查使哺乳动物细胞中ncAA突变发生的机制.
- 提供已成功注册的ncaas的最新列表.
- 讨论GCE技术的当前挑战和未来潜力.
主要方法:
- 审查关于遗传密码扩展的现有文献.
- 收集有关哺乳动物系统中非正规氨基酸结合的数据.
- 对分子机械和突变发生技术的分析.
主要成果:
- 哺乳动物细胞中的遗传密码扩展机制的概述.
- 一个更新的ncAAs成功地纳入蛋白质的目录.
- 确定该领域的关键进展和方法.
结论:
- GCE是研究哺乳动物细胞生物学的一个强大的工具.
- 它对设计下一代生物疗法具有重大前景.
- 应对当前的挑战将释放GCE技术的全部潜力.
更多相关视频
09:20Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells
Published on: July 6, 2021
2.3K
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
8.4K
相关概念视频
The Central Dogma
20.1K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
20.1K
From DNA to Protein
17.9K
The flow of genetic information in cells from DNA to mRNA to protein is described by the central dogma, which states that genes specify the sequence of mRNAs, which in turn specify the sequence of amino acids making up all proteins. The decoding of one molecule to another is performed by specific proteins and RNAs. Because the information stored in DNA is so central to cellular function, it makes intuitive sense that the cell would make mRNA copies of this information for protein synthesis...
17.9K
In-vitro Mutagenesis
13.7K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.7K
Transgenic Organisms
30.8K
Overview
30.8K
Initiation of Translation
30.4K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
30.4K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
